| 000 | 01819 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250512005110.0 | ||
| 264 | 0 | _c19890921 | |
| 008 | 198909s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/BF00304766 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSouhami, R L | |
| 245 | 0 | 0 |
_aIntensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1989 |
||
| 300 |
_a321-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 | _aCarboplatin |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aMelphalan _xadministration & dosage |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aHajichristou, H T | |
| 700 | 1 | _aMiles, D W | |
| 700 | 1 | _aEarl, H M | |
| 700 | 1 | _aHarper, P G | |
| 700 | 1 | _aAsh, C M | |
| 700 | 1 | _aGoldstone, A H | |
| 700 | 1 | _aSpiro, S G | |
| 700 | 1 | _aGeddes, D M | |
| 700 | 1 | _aTobias, J S | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 24 _gno. 5 _gp. 321-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00304766 _zAvailable from publisher's website |
| 999 |
_c2553484 _d2553484 |
||